DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
London
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| MVM F LP | 2024 | Early deployment | $0 | $3.0M | 0 |
| MVM D LP | 2023 | Active deployment | $0 | $11.1M | 0 |
| MVM a LP | 2022 | Active deployment | $6.5M | $14.2M | 0 |
| MVM VI LP | 2022 | Active deployment | $260M | $487M | 0 |
| MVM C LP | 2022 | Active deployment | $7.5M | $14.5M | 0 |
| MVM V (2021) LP | 2021 | Mature | $11.6M | $30.7M | 0 |
| MVM V (2020) LP | 2020 | Mature | $46.5M | $66.1M | 0 |
| MVM III (2020) LP | 2020 | Mature | $4.3M | $8.0M | 0 |
| MVM IV (2019) LP | 2019 | Mature | n/a | $10.4M | 0 |
| MVM V LP | 2018 | Harvest | $142M | $356M | 0 |
| MVM IV Co-Investment I LP | 2015 | Harvest | n/a | $3.5M | 0 |
| MVM IV LP | 2014 | Harvest | $27.0M | $192M | 0 |
| MVM Fund III Limited Partnership | n/a | Unknown | n/a | $23.8M | 0 |
| MVM Fund III (no.2) Limited Partnership | n/a | Unknown | n/a | $1.2M | 0 |
| UK Medical Ventures Fund No. 1 Limited Partnership | n/a | Wound down | n/a | $5.3M | 0 |
| MVM International Life Sciences No.1 Limited Partnership | n/a | Wound down | n/a | $9.5M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| GT Medical Technologies, Inc. | Az | Series d plus | $100M | n/a | Unknown | Jun 9, 2026 |
| Neurent Medical | n/a | Series c | n/a | n/a | Unknown | Feb 11, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Life Sciences | MVM Partners LLP | 1 | 1 | Feb 11, 2026 | One time |
| MVM Partners LLP | Medtech Venture Partners | 1 | 1 | Jun 9, 2026 | One time |
| MVM Partners LLP | Fountain Healthcare Partners | 1 | 1 | Feb 11, 2026 | One time |
| MVM Partners LLP | Evidity Capital LLC | 1 | 1 | Jun 9, 2026 | One time |
| MVM Partners LLP | Enterprise Ireland | 1 | 1 | Feb 11, 2026 | One time |
| MVM Partners LLP | Atlantic Bridge | 1 | 1 | Feb 11, 2026 | One time |
| MVM Partners LLP | Gilde Healthcare | 1 | 1 | Jun 9, 2026 | One time |
| MVM Partners LLP | Femhealth Ventures Management LLC | 1 | 1 | Jun 9, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Kyle Edward Dempsey (Member), Kevin Xu Cheng (Member), Eric Bednarski (Member), Stephen Thomas Reeders (Member), Neil James Akhurst (Member), Thomas Theodore Casdagli (Member), Jack Yuuki Tanaka (Member), ANA Isabella Mihov (Member), Hugo Roy Francis Harrod (Member).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan